From Casetext: Smarter Legal Research

In re Cellcyte Genetics Securities Litigation

United States District Court, W.D. Washington, at Seattle
Jan 20, 2009
Case No. C08-47RSL (W.D. Wash. Jan. 20, 2009)

Opinion

Case No. C08-47RSL.

January 20, 2009


ORDER GRANTING MOTION TO DENY MOTIONS TO DISMISS AS MOOT


This matter comes before the Court on plaintiffs' motion to continue and/or deny as moot defendants' pending motions to dismiss. Defendants do not oppose the motion.

Plaintiffs' motion seeks an order continuing the motions to dismiss until after the Court rules on plaintiffs' pending motion to amend their complaint. An order continuing the motions is unnecessary because the Court has granted plaintiffs' motion to amend.

Defendants' pending motions to dismiss are directed towards the first amended consolidated complaint, but that complaint has been superceded by amendment. Accordingly, the pending motions to dismiss are moot. The Court therefore GRANTS plaintiffs' motion to deny defendants' motions to dismiss as moot (Dkt. #134). The motions to dismiss (Dkt. ## 115, 116, 117, 120) are denied as moot. The denial is without prejudice; defendants may refile motions to dismiss after plaintiffs file their second amended consolidated complaint in the docket.


Summaries of

In re Cellcyte Genetics Securities Litigation

United States District Court, W.D. Washington, at Seattle
Jan 20, 2009
Case No. C08-47RSL (W.D. Wash. Jan. 20, 2009)
Case details for

In re Cellcyte Genetics Securities Litigation

Case Details

Full title:In re CELLCYTE GENETICS SECURITIES LITIGATION This order relates to: All…

Court:United States District Court, W.D. Washington, at Seattle

Date published: Jan 20, 2009

Citations

Case No. C08-47RSL (W.D. Wash. Jan. 20, 2009)